Tad Gerlinger, MD
Adult Reconstructive Orthopaedic Surgery · Chicago, ILNPI 1922097971
Payments from drug & device makers
Across 302 payments — averaging $2876.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$832K
- Kyocera Medical Technologies, Inc.$27K
- Graymont Professional Products IP, LLC$5K
- Vertex$2K
- KCI USA, Inc.$2K
- Medical Device Business Services, Inc.$1K
- plus $164 from 2 others
What the payments were for
- Royalty or licence$270,60742%
- Consulting fees$82,20713%
- Speaking & faculty fees$229,89036%
- Travel & lodging$52,9258%
- Food & beverage$5,7651%
- Gifts$1140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 289 | $831,519 |
| Kyocera Medical Technologies, Inc. | 5 | $27,142 |
| Graymont Professional Products IP, LLC | 1 | $5,000 |
| Vertex | 3 | $2,011 |
| KCI USA, Inc. | 1 | $1,600 |
| Medical Device Business Services, Inc. | 1 | $1,170 |
| Engage Uni, LLC | 1 | $114 |
| Solventum Corporation | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$677,430
- Journey II BCS$125,996
- Journey Uni$97,818
- REAL INTELLIGENCE$78,416
- Legion Revision$72,979
- Journey II CR$72,217
- Legion$56,371
- Journey II XR$47,180
- NAVIO$33,842
- JII Unicondylar Knee System$22,964
- Tandem$21,669
- OR3O Dual Mobility$19,638
- LEGION TKS$18,063
- VISIONAIRE Solutions$16,183
- RI.HIP NAVIGATION$15,902
- REDAPT$15,026
- Navio Surgical System$12,885
- Engage Partial Knee System$11,273
- JOURNEY II UK$11,000
- VERILAST Knees$10,465
How this compares
$868,606 in reported general payments places this provider in the 90th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.
See all adult reconstructive orthopaedic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 74 | $573 |
| Oxycodone Hcl | 95 | $483 |
| Amoxicillin | 216 | $483 |
| Ondansetron OdtOndansetron | 76 | $448 |
| Tramadol Hcl | 178 | $448 |
| Meloxicam | 110 | $345 |
| Cefadroxil | 57 | $339 |
| Clindamycin Hcl | 47 | $72 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Chicago
- Denis NamChicago$3.7M
- Craig della ValleChicago$2.6M
- Hany BedairChicago$1.3M
- Linda SuleimanChicago$1.2M
- Vasili KarasChicago$531K
- Henry FinnChicago$523K
- Brett LevineChicago$260K
- Sara WallaceChicago$148K
- Joshua JacobsChicago$72K
- Adam EdelsteinChicago$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.